J7312 HCPCS code: Injection, dexamethasone, intravitreal implant, 0.1 mg
J7312 is the HCPCS Level II code for injection, dexamethasone, intravitreal implant, 0.1 mg. In 2024 Medicare paid an average of $158.30 per service for J7312 across 223,288 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 14 per day on outpatient hospital claims. Medicare volume fell 12% from 2022 to 2024 (252,555 to 223,288 services). In 2024, about 2,239 clinicians billed Medicare for J7312 for 14,201 beneficiaries; California, Florida, Texas accounted for 25% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2011-01-01 |
| Last action effective | 2011-01-01 |
Who bills J7312 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,239 |
| Medicare beneficiaries | 14,201 |
| States with claims | 49 |
| Share of services in top 3 states (California, Florida, Texas) | 25% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7312, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 252,555 | 16,164 | $195.60 | $155.63 |
| 2023 | 240,982 | 15,341 | $196.19 | $155.86 |
| 2024 | 223,288 | 14,201 | $199.43 | $158.30 |
States with the most J7312 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 20,363 | $159.13 |
| Florida | 18,310 | $159.48 |
| Texas | 16,184 | $157.16 |
| Maryland | 11,679 | $159.41 |
| New York | 10,160 | $159.76 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 14 | Anatomic Consideration |
| practitioner claims | 14 | Anatomic Consideration |
What changed for J7312
- 2011-01-01: J7312 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7312?
J7312 is the HCPCS Level II code for injection, dexamethasone, intravitreal implant, 0.1 mg. Short descriptor: "Dexamethasone intra implant".
How much does Medicare pay for J7312?
In 2024, the average Medicare payment was $158.30 per service (average allowed $199.43).
Does Medicare cover J7312?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J7312 can be billed per day?
14 on outpatient hospital claims; 14 on practitioner claims (NCCI medically unlikely edits).
Related J73 codes
- J7300 — Intrauterine copper contraceptive (paragard)
- J7301 — Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302 — Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- J7303 — Contraceptive supply, hormone containing vaginal ring, each
- J7304 — Contraceptive supply, hormone containing patch, each
- J7306 — Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 — Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308 — Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309 — Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310 — Ganciclovir, 4.5 mg, long-acting implant
- J7311 — Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7313 — Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7312
- Watch J7312 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7312
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.